INSIGHTS ON PHARMACEUTICAL PRODUCTION
-
Imagine The Future: Enhanced Oligonucleotide Synthesis
Learn about flexible control software that has revolutionized the way method creation, evaluation, and process optimizations for scale-up are completed.
-
Sustained-Release Implants: A Targeted Approach To Drug Delivery
Implantable drug delivery systems hold the potential to revolutionize cancer treatment by enhancing efficacy, reducing toxicity, and alleviating the burden of treatment for patients.
-
The Right Polymers For Your Modified Release Multiparticulate Capsule
Pharma companies aiming to tech transfer or scale-up modified release formulations often encounter hurdles when the formulation is not robust. Review how to select the right polymers and ensure you have a robust formulation strategy.
-
Emerging Therapeutics And Personalized Medicine
Here, we examine some impressive examples of personalized medicine applications and delve into the unique challenges of personalized medicine manufacturing.
-
Single-Use Centrifuge: Green Features And Benefits3/14/2023
Explore the green features and process and operation footprint details of a single-use centrifuge being praised for generating less waste.
-
Getting CMC Right For Emerging Technologies12/20/2023
Establishing a chemistry, manufacturing, and controls strategy that proves a clinical program is tightly controlled and can address risk is critical to avoiding the pitfalls that stall many promising therapeutics.
-
High-Velocity Development: Gene Therapy Vs. Small Molecule12/26/2023
Combined with the inherent difficulty of the chemistry behind gene therapy development, its pace, structure, and funding dynamics are unique among treatment modalities.
-
A Rentschler Collaboration Story4/17/2024
Learn how a collaboration between Cytiva and Rentschler Biopharma facilitates the efficient and flexible production of viral vectors.
-
Bridging The Distance To Large-Scale GMP Manufacturing Of Viral Vectors10/26/2023
AGC Biologics discusses its journey to the successful implementation of iCELLis™ bioreactors in their AAV and lentivirus platforms.
PHARMACEUTICAL PRODUCTION SOLUTIONS
-
Learn about a next generation genderless sterile connector for a large range of biopharmaceutical applications. Explore key design features, sterilization specifications, benefits, applications, and more.
-
Subcutaneous
Low - Medium Viscosities
< 100 cP
0.5 - 3 mlArQ® is built around our cyclic olefin copolymer (COC) primary drug container. It offers an autoinjector that is simple to use for the patient, with the flexibility and ability to deliver a wide range of viscosities and volumes.
-
Many production processes in the bulk solids industry include a mixing or homogenization step to achieve consistent product quality. In both continuous and batch processes, important product properties can be subject to fluctuations over time, which must be compensated for.
-
We are your one integrated partner with the expertise to get your therapeutic product to market faster, helping you accelerate, simplify, and de-risk your biologics.
-
Manipulator machines can process a wide range of different containers such as vials, cartridges, and prefilled syringes, either bulk or nested, in order to meet the current pharmaceutical industry requirements and to address the end users' needs. They are designed to ensure the integrity of high-value products such as biotechnology, nuclear, cytotoxic, and more, or to treat different containers with a single machine thanks to the use of manipulator robots. These machines can be customized by joining our professional skills in filling and inspection applications and users' requirements.